Can Teneligliptin Be Added to This Patient's Regimen?

Understanding the Clinical Picture

• Anti-synthetase syndrome (autoimmune inflammatory myopathy + ILD + polyarthritis + mechanic's hands)
• Type 2 diabetes on metformin 500 mg TDS + glimepiride 2 mg OD
• Prednisolone (causing or worsening hyperglycemia - steroid-induced component)
• Methotrexate (immunosuppressant/DMARD)

Why Teneligliptin Makes Pharmacological Sense Here

• 3rd-generation DPP-4 inhibitor with a unique 5-ring structure that gives it high DPP-4 selectivity and a long duration of action (~24 hours with once-daily dosing)
• Effective and safe in renal impairment (including end-stage renal disease) without dose adjustment - relevant since methotrexate use requires monitoring renal function, and renal compromise can complicate diabetic drug choices
• Predominantly metabolized by CYP3A4 (minor pathway) and hydrolysis; eliminated via feces and urine
• Expected HbA1c reduction: 0.5-0.8% when added to existing therapy

Drug Interaction Analysis

One Concern Worth Noting: DPP-4 and Immune Function

• Real-world and trial data have not demonstrated clinically meaningful immunosuppressive additivity with DPP-4 inhibitors at therapeutic doses
• The clinical trial data on teneligliptin show that adverse events including infections were not significantly different from placebo
• Sitagliptin has been reported to be associated with interstitial lung disease (rare), but this is a class concern, not specific to teneligliptin - in a patient who already has ILD from anti-synthetase syndrome, this theoretical risk should be acknowledged, though it is rare and unproven as a significant clinical issue

Practical Recommendations

1. Teneligliptin 20 mg once daily can be added - it is a rational choice given the steroid-induced postprandial hyperglycemia pattern.
2. Monitor blood glucose more closely initially, particularly postprandial readings in the afternoon/evening (when prednisolone effect peaks).
3. Watch for hypoglycemia - triple oral combination (metformin + glimepiride + teneligliptin) in combination with corticosteroid dose fluctuations can occasionally cause hypoglycemia, especially if steroids are tapered. Consider whether glimepiride dose needs review.
4. Renal function monitoring is already mandatory with methotrexate - continue this, and adjust teneligliptin if eGFR falls significantly (though it is one of the safer agents in renal impairment).
5. If glycemic control remains poor despite oral agents, basal insulin (NPH in the evening) is often the most effective intervention for steroid-induced hyperglycemia, and should be the next step if teneligliptin proves insufficient.
6. Consider whether prednisolone dose can be safely reduced (as disease activity allows) as this would also help glycemia.

Summary

• Katzung's Basic and Clinical Pharmacology, 16th Ed., p. 1191 - DPP-4 inhibitor adverse effects and mechanism

Is This Steroid-Induced Diabetes? Almost Certainly Yes.

• Anti-synthetase syndrome diagnosed 5 years ago → likely on prednisolone for most of that time
• Diabetes diagnosed only 2 weeks back
• No mention of diabetes or pre-existing glucose intolerance before steroids

Why Did It Take 5 Years to Develop?

• 1 month of use: hazard ratio 1.20 for developing diabetes
• 3 months: HR 1.43
• 6 months: HR 1.48

• Increased hepatic gluconeogenesis
• Peripheral insulin resistance (mainly in muscle and fat)
• Impaired incretin effect (GLP-1 activity reduced from ~70% to ~40% after just 12 days of prednisolone 37.5 mg)
• Direct beta-cell dysfunction and inflammation
• Increased free fatty acids worsening insulin resistance further

• 25% of patients on prednisolone >30 mg develop steroid-induced hyperglycemia
• Even low-dose prednisolone (5-10 mg) over years carries cumulative risk
• The threshold dose is >5 mg/day prednisolone equivalent for chronic use

How Is Steroid-Induced Diabetes Different from Regular Type 2?

Practical Implication for This Patient

1. HbA1c may underestimate severity - because steroid-induced hyperglycemia is predominantly postprandial, fasting glucose and HbA1c can appear near-normal while postprandial spikes are dangerously high. A 2-hour post-meal glucose or CGM gives a more accurate picture than HbA1c alone.
2. Teneligliptin becomes even more rational - its glucose-dependent, postprandial-targeting mechanism directly addresses the steroid-induced pattern. This was discussed in the previous response.
3. If prednisolone is ever tapered or stopped, diabetes may partially or fully resolve - monitor glucose and be prepared to reduce or stop anti-diabetic medications to avoid hypoglycemia.
4. If prednisolone dose increases (e.g., during a disease flare of anti-synthetase syndrome), glycemic control will worsen - may need NPH insulin in the morning/afternoon at that point.
5. Screen for complications - even though diagnosed only 2 weeks ago, she has likely had postprandial hyperglycemia for months or years before formal diagnosis. Baseline retinal exam, urine albumin:creatinine ratio, and neuropathy assessment are warranted.

Bottom Line

• Harrison's Principles of Internal Medicine 22E, p. 3264 - glucocorticoid effects on glucose homeostasis

Can Dapagliflozin Be Added? - A Cautious No, With Explanation

The Problem Areas

• Prednisolone (suppresses cellular and humoral immunity)
• Methotrexate (suppresses T-cell function, neutrophil activity)

• Vulvovaginal/genital mycotic (fungal) infections - baseline risk with dapagliflozin alone is 6.9-8.4% in women; in an immunosuppressed woman this is likely considerably higher
• Urinary tract infections and urosepsis - dapagliflozin increases UTI risk (OR 1.17); prednisolone masks fever and pain, so a UTI can silently progress to pyelonephritis or urosepsis before it is recognized
• Fournier's gangrene (necrotizing fasciitis of genitalia) - rare but life-threatening; immunosuppressed patients are at higher risk

• She is on prednisolone, which increases glucagon and promotes lipolysis - priming the ketogenic state
• She has steroid-induced diabetes with likely residual beta-cell stress
• Any disease flare of anti-synthetase syndrome could cause reduced oral intake - a known precipitant of euDKA with SGLT2 inhibitors
• euDKA is particularly dangerous because blood glucose is normal or only mildly elevated, so it is frequently missed until the patient is severely acidotic

What to Do Instead

Full Prescription

Patient: [Name]
Date: July 12, 2026
Diagnosis: 
  1. Anti-synthetase syndrome (Jo-1/anti-aminoacyl tRNA synthetase antibody 
     positive) with ILD - on treatment
  2. Type 2 Diabetes Mellitus - Glucocorticoid-induced (newly diagnosed)

Rx:

1. Tab. Metformin 500 mg  
   Three times daily (TDS) with meals  
   [Continue existing]

2. Tab. Glimepiride 2 mg  
   Once daily (OD), before breakfast  
   [Continue existing - review dose if hypoglycemia occurs, 
    especially if prednisolone is tapered]

3. Tab. Prednisolone [dose as per rheumatologist]  
   [Continue as directed]

4. Tab. Methotrexate [dose as per rheumatologist]  
   Once weekly  
   [Continue as directed] + Folic acid 5 mg on non-MTX days

5. Tab. Teneligliptin 20 mg  ← NEW ADDITION
   Once daily (OD), in the morning  
   (Targets postprandial hyperglycemia; glucose-dependent, 
    low hypoglycemia risk, safe with all current drugs, 
    renal-dose adjustment not required)

Advice:
- Monitor fasting AND 2-hour post-lunch/dinner glucose (steroid 
  hyperglycemia peaks in afternoon/evening)
- Check HbA1c + fasting glucose after 3 months
- Baseline: urine albumin:creatinine ratio, fundus examination, 
  foot examination (for diabetic complication screening - she may 
  have had occult hyperglycemia for months before formal diagnosis)
- Monitor renal function (eGFR, serum creatinine) every 3 months 
  (mandatory with methotrexate; also guides diabetes drug dosing)
- If prednisolone dose increases during a flare: anticipate 
  worsening glycemia - may need morning NPH insulin 
- If prednisolone is successfully tapered/stopped: reassess need 
  for all antidiabetic medications; glimepiride dose reduction 
  first to avoid hypoglycemia
- Calcium 500 mg + Vitamin D3 1000 IU daily (steroid osteoporosis 
  prophylaxis if not already prescribed)
- Avoid NSAIDs (risk of methotrexate toxicity via reduced 
  renal clearance)

Why NOT Dapagliflozin - Summary in One Line

Insulin for This Patient - Complete Guide

First: Which Mixed Insulin and Why?

• Patient cannot or will not do multiple injections
• Fixed meal schedule is maintained
• Steroid is taken once daily in the morning (most common pattern for prednisolone)

• Prednisolone peaks in the afternoon, causing maximum postprandial glucose in the afternoon/evening
• A morning dose of premixed insulin covers the steroid glucose peak directly
• Overnight hypoglycemia risk is low since prednisolone effect wanes by night

Dose Calculation for This 60 kg Patient

Initial dose = 0.1 units/kg/day for every 10 mg of prednisolone

Titration Schedule

What to Do With Existing Oral Drugs?

Full Prescription

Patient: [Name], 60 kg
Diagnosis: Anti-synthetase syndrome + Glucocorticoid-induced T2DM

Rx:

1. Inj. Mixtard 30/70 (Premixed Human Insulin 70/30)
   ── 12 units subcutaneous, 30 minutes before BREAKFAST
   ── Titrate by 2 units every 2-3 days based on pre-dinner glucose
   ── Target pre-dinner glucose: 100-180 mg/dL (6-10 mmol/L)
   ── Target fasting glucose: 80-130 mg/dL
   ── Use insulin pen or 1 mL syringe, rotate injection sites
      (abdomen preferred for consistent absorption)

   [If prednisolone is twice daily: add evening dose of 6 units 
    before dinner, titrate separately based on fasting morning glucose]

2. Tab. Metformin 500 mg
   Three times daily (TDS) with meals — CONTINUE

3. Tab. Glimepiride 2 mg
   STOP (discontinue to avoid hypoglycemia with insulin)

4. Tab. Teneligliptin 20 mg OD (morning)
   CONTINUE if already started — helps postprandial control, 
   reduces insulin dose requirement, no hypoglycemia risk

5. Tab. Prednisolone [existing dose] — Continue as directed

6. Tab. Methotrexate [existing dose] once weekly — Continue
   + Tab. Folic acid 5 mg on all non-MTX days

7. Tab. Calcium 500 mg + Vit D3 1000 IU — once daily
   (steroid osteoporosis prophylaxis)

Blood Glucose Monitoring:
   - Fasting (morning, before breakfast)
   - Pre-dinner (2 pm - 5 pm) — most important reading for 
     titrating morning premixed insulin
   - 2 hrs post-dinner (if feasible)
   - Record daily and review weekly

Sick Day Rules:
   - NEVER stop insulin during illness even if not eating
   - Reduce dose by 20% if eating less than half usual food
   - Check glucose every 4-6 hours during illness
   - Seek medical review if glucose >300 mg/dL or vomiting

IMPORTANT - Steroid Taper Advice:
   - If prednisolone dose is reduced by any amount, REDUCE 
     insulin dose by 10-20% on the same day
   - If prednisolone is stopped: reduce insulin by 50% 
     immediately and monitor closely - may be able to stop 
     insulin entirely within days
   - After stopping insulin: restart glimepiride and reassess 
     need for all diabetic medications

Why This Approach Works

• The 30% short-acting component covers breakfast postprandial glucose
• The 70% intermediate-acting (NPH) component peaks in 4-8 hours, covering afternoon/evening glucose when prednisolone is most active
• Duration matches prednisolone's 12-18 hour effect
• Overnight hypoglycemia is minimized because both drug effects wane together

Mixtard 30/70 - Weight-Based Calculation for 60 kg Patient

Step 1: Calculate Total Daily Dose (TDD)

Step 2: Split Morning : Evening

Morning = 2/3 of TDD Evening = 1/3 of TDD

• Insulin resistance and glucose load are higher during the daytime (especially with morning prednisolone)
• Evening dose is smaller to avoid nocturnal hypoglycemia

Dose Calculation for This 60 kg Patient

Full Starting Prescription

Inj. Mixtard 30/70 (Human Premixed Insulin)

  Morning:  12 units  subcutaneous
            → 30 minutes BEFORE BREAKFAST

  Evening:  6 units   subcutaneous
            → 30 minutes BEFORE DINNER

  Total Daily Dose: 18 units
  Injection site: Abdomen (rotate sites)

Titration - Which Glucose Drives Which Dose?

If pre-dinner glucose > 180 mg/dL (>10 mmol/L)
→ Increase MORNING dose by 2 units every 3 days

If fasting glucose > 130 mg/dL (>7.2 mmol/L)  
→ Increase EVENING dose by 2 units every 3 days

If any glucose < 70 mg/dL (hypoglycemia)
→ Reduce that dose by 10-20% immediately

Summary Table at a Glance

Weight:           60 kg
TDD:              0.3 U/kg = 18 units
                  ↓
Morning (2/3):    12 units before breakfast
Evening (1/3):    6 units before dinner
                  ↓
Titrate morning → by pre-dinner glucose
Titrate evening → by fasting glucose
                  ↓
Target:
  Fasting:        80-130 mg/dL
  Pre-dinner:     100-180 mg/dL
  Post-meal 2hr:  < 180 mg/dL

Important Notes

1. Glimepiride must be stopped when starting twice-daily premixed insulin - high hypoglycemia risk
2. Metformin 500 mg TDS - continue - reduces insulin resistance, lowers total insulin dose needed
3. Teneligliptin 20 mg OD - can continue - helps postprandial control, no added hypoglycemia risk
4. If prednisolone is tapered: reduce morning insulin dose by 2-4 units for every 10 mg reduction in prednisolone dose on the same day
5. If prednisolone dose increases (disease flare): increase morning dose by 2-4 units and monitor pre-dinner glucose closely
6. Mixtard must be gently rolled (not shaken) to resuspend the NPH component before injecting - always check the cloudy suspension is uniform

Mixtard 30/70 - Starting Dose vs Titration: The Full Picture

The Core Principle First

The Golden Rule of Premixed Twice-Daily Insulin

MORNING DOSE  ←  controlled by  →  PRE-DINNER glucose
EVENING DOSE  ←  controlled by  →  FASTING (FBS) glucose

• The morning injection works throughout the day → its result shows up at pre-dinner
• The evening injection works overnight → its result shows up at next morning FBS

Complete Titration Algorithm

Targets to Aim For

Step-by-Step Titration

EVENING DOSE - Titrated by FBS (Fasting Morning Glucose)

MORNING DOSE - Titrated by Pre-Dinner Glucose

Where Does 2hr PPBS Fit?

Worked Example for This Patient (60 kg, Starting Dose 12-6 units)

Day 1-3:   Morning 12u / Evening 6u
           FBS readings: 210, 195, 220 mg/dL → average > 181
           → Increase EVENING dose by 2u → now 8u

Day 4-6:   Morning 12u / Evening 8u
           FBS readings: 150, 165, 140 mg/dL → between 130-180
           → Increase EVENING dose by 1u → now 9u

Day 7-9:   Morning 12u / Evening 9u
           FBS readings: 118, 122, 115 mg/dL → TARGET REACHED ✅
           → Evening dose stays at 9u

           Now titrate morning dose:
           Pre-dinner readings: 210, 230, 195 → average >181
           → Increase MORNING dose by 2u → now 14u

Day 10-12: Morning 14u / Evening 9u
           Pre-dinner readings: 165, 155, 170 → between 130-180
           → Increase MORNING dose by 1u → now 15u

Day 13+:   Morning 15u / Evening 9u
           Pre-dinner: 130-160 → TARGET REACHED ✅
           FINAL DOSE: 15u morning / 9u evening
           (Note: this is close to 2:1 ratio, consistent with 2/3:1/3 rule)

Key Rules to Remember

1. Titrate one dose at a time - always fix FBS first (evening dose), then pre-dinner (morning dose)
2. Wait 3 days before each adjustment - look at the trend, not a single reading
3. Hypoglycemia overrides everything - reduce dose immediately, investigate cause
4. In this steroid patient - if prednisolone dose changes, adjust morning dose first (it drives daytime steroid hyperglycemia)
5. There is no upper dose limit - titrate until targets are met. Many T2DM patients end up on 30-40 units per dose
6. PPBS helps confirm but FBS and pre-dinner are the primary titration drivers

Summary in One Box

FBS high?      → Increase EVENING dose
Pre-dinner high? → Increase MORNING dose
PPBS high?     → Confirms the above; use to fine-tune
Hypoglycemia?  → Reduce relevant dose immediately

Review every 3 days
Change one dose at a time
Target: FBS 80-130, Pre-dinner 100-180, PPBS <180